BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.030
-0.070 (-6.36%)
At close: Feb 4, 2026, 4:00 PM EST
1.030
0.00 (0.00%)
After-hours: Feb 4, 2026, 4:00 PM EST
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $9.14 million as of February 4, 2026. Its market cap has decreased by -32.78% in one year.
Market Cap
9.14M
Enterprise Value
5.27M
1-Year Change
-32.78%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has increased from $6.50M to $9.14M, an increase of 40.65%. That is a compound annual growth rate of 8.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 9.80M | -5.77% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 10.81M |
| NuCana | 10.74M |
| Akari Therapeutics, | 10.73M |
| Phio Pharmaceuticals | 10.63M |
| GridAI Technologies | 10.52M |
| Chemomab Therapeutics | 10.28M |
| Edesa Biotech | 10.25M |
| Quince Therapeutics | 10.02M |